0001562180-22-005012.txt : 20220610 0001562180-22-005012.hdr.sgml : 20220610 20220610121250 ACCESSION NUMBER: 0001562180-22-005012 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220608 FILED AS OF DATE: 20220610 DATE AS OF CHANGE: 20220610 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chiquette Elaine CENTRAL INDEX KEY: 0001891528 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39362 FILM NUMBER: 221008141 MAIL ADDRESS: STREET 1: C/O GELESIS, INC. STREET 2: 501 BOYLSTON STREET, SUITE 6102 CITY: BOSTON STATE: MA ZIP: 02116 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GELESIS HOLDINGS, INC. CENTRAL INDEX KEY: 0001805087 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 844730610 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 501 BOYLSTON STREET, SUITE 6102 CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 857-327-7737 MAIL ADDRESS: STREET 1: 501 BOYLSTON STREET, SUITE 6102 CITY: BOSTON STATE: MA ZIP: 02116 FORMER COMPANY: FORMER CONFORMED NAME: CAPSTAR SPECIAL PURPOSE ACQUISITION CORP. DATE OF NAME CHANGE: 20200227 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2022-06-08 false 0001805087 GELESIS HOLDINGS, INC. GLS 0001891528 Chiquette Elaine GELESIS HOLDINGS, INC. 501 BOYLSTON STREET, SUITE 6102 BOSTON MA 02116 false true false false Chief Scientific Officer Common Stock 2022-06-08 4 A false 80500.00 A 263079.00 D Stock Options (Right to buy) 3.78 2022-06-08 4 A false 80500.00 0.00 A 2032-06-08 Common Stock 80500.00 80500.00 D Represents a grant of restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's common stock upon vesting and settlement. 25% of these RSUs shall vest on May 16, 2023, with the remaining vesting in twelve (12) equal quarterly installments thereafter, subject to the reporting person's continued service on each such vesting date. 25% of the shares underlying this option shall vest and become exercisable on May 16, 2023, with the remainder vesting in twelve (12) equal quarterly installments thereafter, subject to the reporting person's continued service on each such vesting date. /s/ David Abraham, Attorney-in-Fact 2022-06-10